The potential of HDAC inhibitors as cognitive enhancers - PubMed (original) (raw)
Review
The potential of HDAC inhibitors as cognitive enhancers
Johannes Gräff et al. Annu Rev Pharmacol Toxicol. 2013.
Abstract
Histone acetylation is a prominent epigenetic modification of the central nervous system that is unequivocally associated with an increase in the rate of gene transcription. Because gene transcription, in turn, plays an important role in long-lasting forms of memory, histone acetylation generally favors long-term memory, whereas histone deacetylation impinges on it. Histone acetylation is also amenable to pharmacological interventions-predominantly by the use of histone deacetylase (HDAC) inhibitors-and has therefore spurred considerable interest as a putative target of cognitive enhancement. Because of the ubiquitous presence of histone acetylation, HDAC inhibitors have great potential not only to treat cognitive impairment resulting from neurodevelopmental and neurodegenerative disorders but also to serve as cognitive enhancers for the cognitively healthy. In this review, we summarize the state of the art of HDAC inhibitors as cognitive treatments or cognitive enhancers; describe a new model of their mode of action, epigenetic priming; and caution against their unsupervised usage, despite their overall great promise.
Similar articles
- Histone Deacetylase Inhibitors as Cognitive Enhancers and Modifiers of Mood and Behavior.
Pal D, Sahu P, Mishra AK, Hagelgans A, Sukocheva O. Pal D, et al. Curr Drug Targets. 2023;24(9):728-750. doi: 10.2174/1389450124666221207090108. Curr Drug Targets. 2023. PMID: 36475351 Review. - Targeting the correct HDAC(s) to treat cognitive disorders.
Fischer A, Sananbenesi F, Mungenast A, Tsai LH. Fischer A, et al. Trends Pharmacol Sci. 2010 Dec;31(12):605-17. doi: 10.1016/j.tips.2010.09.003. Epub 2010 Oct 25. Trends Pharmacol Sci. 2010. PMID: 20980063 Review. - HDAC modulation and cell death in the clinic.
Dell'Aversana C, Lepore I, Altucci L. Dell'Aversana C, et al. Exp Cell Res. 2012 Jul 1;318(11):1229-44. doi: 10.1016/j.yexcr.2012.01.025. Epub 2012 Feb 3. Exp Cell Res. 2012. PMID: 22336671 Review. - Epigenetic histone acetylation and deacetylation mechanisms in experimental models of neurodegenerative disorders.
Konsoula Z, Barile FA. Konsoula Z, et al. J Pharmacol Toxicol Methods. 2012 Nov-Dec;66(3):215-20. doi: 10.1016/j.vascn.2012.08.001. Epub 2012 Aug 10. J Pharmacol Toxicol Methods. 2012. PMID: 22902970 Review. - Targeting histone deacetylase in thyroid cancer.
Russo D, Durante C, Bulotta S, Puppin C, Puxeddu E, Filetti S, Damante G. Russo D, et al. Expert Opin Ther Targets. 2013 Feb;17(2):179-93. doi: 10.1517/14728222.2013.740013. Epub 2012 Dec 13. Expert Opin Ther Targets. 2013. PMID: 23234477 Review.
Cited by
- Role of histone deacetylase inhibitors in non-neoplastic diseases.
Zhou C, Zhao D, Wu C, Wu Z, Zhang W, Chen S, Zhao X, Wu S. Zhou C, et al. Heliyon. 2024 Jul 2;10(13):e33997. doi: 10.1016/j.heliyon.2024.e33997. eCollection 2024 Jul 15. Heliyon. 2024. PMID: 39071622 Free PMC article. Review. - Domestication Gene Mlx and Its Partner Mondo Are Involved in Controlling the Larval Body Size and Cocoon Shell Weight of Bombyx mori.
Qin X, Jiang L, Zhao P, Lin Y, Zhang Y, Xia Q. Qin X, et al. Int J Mol Sci. 2024 Mar 18;25(6):3427. doi: 10.3390/ijms25063427. Int J Mol Sci. 2024. PMID: 38542400 Free PMC article. - Epigenetic Regulation in Schizophrenia: Focus on Methylation and Histone Modifications in Human Studies.
Delphin N, Aust C, Griffiths L, Fernandez F. Delphin N, et al. Genes (Basel). 2024 Feb 21;15(3):272. doi: 10.3390/genes15030272. Genes (Basel). 2024. PMID: 38540331 Free PMC article. Review. - ZNF787 and HDAC1 Mediate Blood-Brain Barrier Permeability in an In Vitro Model of Alzheimer's Disease Microenvironment.
Zhang L, Zhu B, Zhou X, Ning H, Zhang F, Yan B, Chen J, Ma T. Zhang L, et al. Neurotox Res. 2024 Feb 8;42(1):12. doi: 10.1007/s12640-024-00693-4. Neurotox Res. 2024. PMID: 38329647 - Unlocking the epigenetic symphony: histone acetylation's impact on neurobehavioral change in neurodegenerative disorders.
Basavarajappa BS, Subbanna S. Basavarajappa BS, et al. Epigenomics. 2024 Mar;16(5):331-358. doi: 10.2217/epi-2023-0428. Epub 2024 Feb 7. Epigenomics. 2024. PMID: 38321930 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources